Septal Chondromucosal Composite Graft for Post-oncological Subtotal Lower Eyelid Reconstruction: A Single-Center Experience

鼻中隔软骨黏膜复合移植用于肿瘤术后下睑部分重建:单中心经验

阅读:1

Abstract

Malignant cutaneous eyelid tumors account for approximately 5 to 10% of all cutaneous cancers. Basal cell carcinoma constitutes the majority of all eyelid malignancies, accounting for 86% to 96% of all cases. We report a series of 31 patients with full-thickness lower eyelid defects after cancer excision reconstructed via chondromucosal grafts from the nasal septum and the Mustardé flap, which resulted in stable lid margins with a low complication rate. Postoperative histological examination revealed that, in all patients, the tumor was completely included in the submitted specimen. Patients were followed up for at least 12 months postoperatively. No necrosis, hematoma, or infection was observed, except for one case of wound dehiscence, and no patients suffered from corneal irritation. Only one patient presented mild scleral show. On the basis of our clinical experience, we recommend the use of a septal chondromucosal 2 composite graft in conjunction with the Mustardé flap for the reconstruction of lower eyelid full- fullthickness defect.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。